Cataract Removal Clinical Trials

Clinical trials related to Cataract Removal Procedure

A Prospective Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of an Intraocular Lens With a Virtual Aperture Optic

Status: Recruiting
Location: See all (8) locations...
Intervention Type: Device, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Cataracts are cloudy areas in the lens of the eye that can cause changes in vision. Symptoms of cataracts include cloudy or fuzzy vision and sensitivity to glare. Cataract extraction with Intraocular lens (IOL) implantation is the most commonly performed surgical procedure in the world. Presbyopia affects almost everyone over the age of 50. With age, the natural crystalline lens loses its ability to change shape, or accommodate, to focus on near distances. Thus, individuals with excellent distance vision will still need to wear spectacles for near tasks such as reading, and intermediate tasks such as computer work.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 75
Healthy Volunteers: f
View:

• Adults, Age 40 to 75 years at the time of surgery, diagnosed with bilateral cataracts with planned cataract removal by phacoemulsification with a clear cornea incision and posterior chamber IOL implantation;

• Preoperative best-corrected distance visual acuity (BCDVA) worse than 20/30 Snellen;

• Clear intraocular media, other than cataract;

• Calculated lens power within the available range (available range of +16 D to +24 D);

• Preoperative keratometric astigmatism of less than 0.75 D in both operative eyes;

• Potential for postoperative BCDVA of 20/25 or better in each eye after cataract removal and IOL implantation;

• Able to comprehend and have signed a statement of informed consent;

• Availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visits;

Locations
Other Locations
Portugal
Portugal Site 2
RECRUITING
Coimbra
Portugal Site 3
NOT_YET_RECRUITING
Lisbon
Spain
Oftalvist Alicante
RECRUITING
Alicante
Ceuta Medical Center
RECRUITING
Ceuta
Hospital Arruzafa
RECRUITING
Córdoba
Oftalvist Madrid
RECRUITING
Madrid
Augenclinic Mallorca
RECRUITING
Palma De Mallorca
Switzerland
Orasis
RECRUITING
Reinach
Time Frame
Start Date: 2025-08-07
Estimated Completion Date: 2027-09
Participants
Target number of participants: 60
Treatments
Experimental: Z+ VAO IOL
FG-80030.1 hydrophobic
Related Therapeutic Areas
Sponsors
Leads: Z Optics, Inc.

This content was sourced from clinicaltrials.gov